Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Table of Contents
1 MARKET OVERVIEW OF DRUG-DEVICE COMBINATION PRODUCTS 1
1.1 Drug-Device Combination Products Market Overview 1
1.1.1 Drug-Device Combination Products Product Scope 1
1.1.2 Drug-Device Combination Products Market Status and Outlook 2
1.2 Drug-Device Combination Products Market Overview by Type 4
1.2.1 Drug-Coated Device 4
1.2.2 Prefilled Drug Delivery Systems 5
1.2.3 Nebulizer & Inhaler 7
1.2.4 Transdermal Delivery System 9
1.3 Global Drug-Device Combination Products Market Size by Type 10
1.3.1 Global Drug-Device Combination Products Market Size Overview by Type (2016-2027) 11
1.3.2 Global Drug-Device Combination Products Historic Market Size Review by Type (2016-2021) 12
1.3.3 Global Drug-Device Combination Products Forecasted Market Size by Type (2022-2027) 13
1.4 Key Regions Market Size Segment by Type 14
1.4.1 North America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 14
1.4.2 Europe Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 15
1.4.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 16
1.4.4 South America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 17
1.4.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Type (2016-2021) 18
2 DRUG-DEVICE COMBINATION PRODUCTS MARKET COMPETITION BY COMPANY 20
2.1 Global Drug-Device Combination Products Market Size by Players (2019-2021) 20
2.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020) 22
2.3 Founded Date of Key Drug-Device Combination Products Players 23
2.4 Global Top Players Drug-Device Combination Products Headquarters and Area Served 23
2.5 Key Players Drug-Device Combination Products Product Solution and Service 24
2.6 Competitive Status 25
2.6.1 Drug-Device Combination Products Market Concentration Rate 25
2.6.2 Mergers & Acquisitions, Expansion Plans 26
3 DRUG-DEVICE COMBINATION PRODUCTS STATUS AND OUTLOOK BY REGION 28
3.1 Global Drug-Device Combination Products Market Size Overview by Region 2016 VS 2021 VS 2027 28
3.2 Global Drug-Device Combination Products Market Size by Region (2016-2027) 29
3.3 Global Drug-Device Combination Products Historic Market Size by Region (2016-2021) 29
3.4 Global Drug-Device Combination Products Market Size Forecast by Region (2022-2027) 30
4 DRUG-DEVICE COMBINATION PRODUCTS MARKET OVERVIEW BY APPLICATION 32
4.1 Drug-Device Combination Products Market Segment by Application 32
4.1.1 Hospital & Clinic 32
4.1.2 Retail Pharmacies 33
4.2 Global Drug-Device Combination Products Market Size by Application 34
4.2.1 Global Drug-Device Combination Products Market Size Overview by Application (2016-2027) 34
4.2.2 Global Drug-Device Combination Products Historic Market Size by Application (2016-2021) 36
4.2.3 Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027) 36
4.3 Key Regions Market Size Segment by Application 37
4.3.1 North America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 37
4.3.2 Europe Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 38
4.3.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 39
4.3.4 South America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 40
4.3.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Application (2016-2021) 41
5 NORTH AMERICA 43
5.1 North America Drug-Device Combination Products Market Size by Country (2016-2027) 43
5.2 United States 44
5.3 Canada 45
5.4 Mexico 45
6 EUROPE 46
6.1 Europe Drug-Device Combination Products Market Size by Country (2016-2027) 46
6.2 Germany 47
6.3 France 48
6.4 U.K. 48
6.5 Italy 49
6.6 Russia 49
6.7 Rest of Europe 50
7 ASIA-PACIFIC 51
7.1 Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2027) 51
7.2 China 53
7.3 Japan 53
7.4 South Korea 54
7.5 Southeast Asia 55
7.6 India 55
7.7 Australia 56
7.8 Rest of Asia-Pacific 56
8 SOUTH AMERICA 57
8.1 South America Drug-Device Combination Products Market Size by Country (2016-2027) 57
8.2 Brazil 58
8.3 Rest of South America 58
9 MIDDLE EAST & AFRICA 59
9.1 Middle East & Africa Drug-Device Combination Products Market Size by Country 59
9.2 Middle East 60
9.3 Africa 60
10 COMPANY PROFILES AND KEY FIGURES IN DRUG-DEVICE COMBINATION PRODUCTS BUSINESS 61
10.1 GSK 61
10.1.1 GSK Corporation Information 61
10.1.2 GSK Introduction and Business Overview 61
10.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 62
10.1.4 GSK Drug-Device Combination Products Offered 62
10.1.5 GSK Recent Development 64
10.2 Novo Nordisk 64
10.2.1 Novo Nordisk Corporation Information 64
10.2.2 Novo Nordisk Introduction and Business Overview 65
10.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 65
10.2.4 Novo Nordisk Drug-Device Combination Products Offered 66
10.2.5 Novo Nordisk Recent Development 66
10.3 Eli Lilly 66
10.3.1 Eli Lilly Corporation Information 66
10.3.2 Eli Lilly Introduction and Business Overview 67
10.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 67
10.3.4 Eli Lilly Drug-Device Combination Products Offered 67
10.3.5 Eli Lilly Recent Development 68
10.4 AstraZeneca 69
10.4.1 AstraZeneca Corporation Information 69
10.4.2 AstraZeneca Introduction and Business Overview 69
10.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 69
10.4.4 AstraZeneca Drug-Device Combination Products Offered 70
10.4.5 AstraZeneca Recent Development 71
10.5 Sanofi 71
10.5.1 Sanofi Corporation Information 71
10.5.2 Sanofi Introduction and Business Overview 72
10.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 72
10.5.4 Sanofi Drug-Device Combination Products Offered 72
10.5.5 Sanofi Recent Development 73
10.6 Boston Scientific 73
10.6.1 Boston Scientific Corporation Information 73
10.6.2 Boston Scientific Introduction and Business Overview 74
10.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 74
10.6.4 Boston Scientific Drug-Device Combination Products Offered 75
10.6.5 Boston Scientific Recent Development 76
10.7 Abbott 76
10.7.1 Abbott Corporation Information 76
10.7.2 Abbott Introduction and Business Overview 77
10.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 77
10.7.4 Abbott Drug-Device Combination Products Offered 77
10.8 Boehringer Ingelheim 78
10.8.1 Boehringer Ingelheim Corporation Information 78
10.8.2 Boehringer Ingelheim Introduction and Business Overview 79
10.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 79
10.8.4 Boehringer Ingelheim Drug-Device Combination Products Offered 79
10.8.5 Boehringer Ingelheim Recent Development 80
10.9 Medtronic 81
10.9.1 Medtronic Corporation Information 81
10.9.2 Medtronic Introduction and Business Overview 81
10.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 82
10.9.4 Medtronic Drug-Device Combination Products Offered 82
10.9.5 Medtronic Recent Development 83
10.10 Mylan 83
10.10.1 Mylan Corporation Information 83
10.10.2 Mylan Introduction and Business Overview 84
10.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 84
10.10.4 Mylan Drug-Device Combination Products Offered 85
10.10.5 Mylan Recent Development 86
10.11 3M 86
10.11.1 3M Corporation Information 86
10.11.2 3M Introduction and Business Overview 86
10.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 87
10.11.4 3M Drug-Device Combination Products Offered 87
10.12 Hisamitsu 88
10.12.1 Hisamitsu Corporation Information 88
10.12.2 Hisamitsu Introduction and Business Overview 89
10.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 89
10.12.4 Hisamitsu Drug-Device Combination Products Offered 90
10.13 Smith & Nephew 90
10.13.1 Smith & Nephew Corporation Information 90
10.13.2 Smith & Nephew Introduction and Business Overview 91
10.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 91
10.13.4 Smith & Nephew Drug-Device Combination Products Offered 91
10.13.5 Smith & Nephew Recent Development 93
10.14 Molnlycke 93
10.14.1 Molnlycke Corporation Information 93
10.14.2 Molnlycke Introduction and Business Overview 93
10.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 94
10.14.4 Molnlycke Drug-Device Combination Products Offered 94
10.15 Teleflex 95
10.15.1 Teleflex Corporation Information 95
10.15.2 Teleflex Introduction and Business Overview 95
10.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 96
10.15.4 Teleflex Drug-Device Combination Products Offered 96
10.15.5 Teleflex Recent Development 97
10.16 BD 97
10.16.1 BD Corporation Information 97
10.16.2 BD Introduction and Business Overview 97
10.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 98
10.16.4 BD Drug-Device Combination Products Offered 98
10.17 Lepu Medical 99
10.17.1 Lepu Medical Corporation Information 99
10.17.2 Lepu Medical Introduction and Business Overview 99
10.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 100
10.17.4 Lepu Medical Drug-Device Combination Products Offered 100
10.18 MicroPort 102
10.18.1 MicroPort Corporation Information 102
10.18.2 MicroPort Introduction and Business Overview 102
10.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 103
10.18.4 MicroPort Drug-Device Combination Products Offered 103
10.19 Terumo 104
10.19.1 Terumo Corporation Information 104
10.19.2 Terumo Introduction and Business Overview 105
10.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 105
10.19.4 Terumo Drug-Device Combination Products Offered 105
10.20 B. Braun 106
10.20.1 B. Braun Corporation Information 106
10.20.2 B. Braun Introduction and Business Overview 107
10.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 107
10.20.4 B. Braun Drug-Device Combination Products Offered 107
10.21 Antares Pharma 109
10.21.1 Antares Pharma Corporation Information 109
10.21.2 Antares Pharma Introduction and Business Overview 110
10.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (2019-2021) 110
10.21.4 Antares Pharma Drug-Device Combination Products Offered 110
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 112
11.1 Drug-Device Combination Products Key Raw Materials 112
11.1.1 Key Raw Materials 112
11.1.2 Key Raw Materials Market Concentration Rate 112
11.1.3 Raw Materials Key Suppliers 112
11.2 Manufacturing Cost Structure 113
11.2.1 Raw Materials 113
11.2.2 Labor Cost 113
11.2.3 Manufacturing Expenses 113
11.3 Drug-Device Combination Products Industrial Chain Analysis 114
11.4 Drug-Device Combination Products Market Dynamics 114
11.4.1 Drug-Device Combination Products Industry Trends 114
11.4.2 Drug-Device Combination Products Market Drivers 115
11.4.3 Drug-Device Combination Products Market Challenges 116
11.4.4 Drug-Device Combination Products Market Restraints 116
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 117
12.1 Sales Channel 117
12.2 Drug-Device Combination Products Distributors 118
12.3 Drug-Device Combination Products Downstream Customers 119
13 RESEARCH FINDING/CONCLUSION 122
14 METHODOLOGY AND DATA SOURCE 124
14.1 Methodology/Research Approach 124
14.1.1 Research Programs/Design 124
14.1.2 Market Size Estimation 125
14.1.3 Market Breakdown and Data Triangulation 126
14.2 Data Source 127
14.2.1 Secondary Sources 127
14.2.2 Primary Sources 128
14.3 Disclaimer 129
14.4 Author List 130
List of Tables
Table 1. Major Company of Drug-Coated Device 5
Table 2. Major Company of Prefilled Drug Delivery Systems 6
Table 3. Major Company of Nebulizer & Inhaler 8
Table 4. Major Company of Transdermal Delivery System 10
Table 5. Global Drug-Device Combination Products Revenue by Type: 2016 VS 2021 VS 2027 (US$ Million) 11
Table 6. Global Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million) 12
Table 7. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021) 12
Table 8. Global Drug-Device Combination Products Revenue by Type (2022-2027) & (US$ Million) 13
Table 9. Global Drug-Device Combination Products Revenue Market Share by Type (2022-2027) 13
Table 10. North America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million) 14
Table 11. Europe Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million) 15
Table 12. Asia-Pacific Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million) 16
Table 13. South America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million) 17
Table 14. Middle East and Africa Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million) 18
Table 15. Global Drug-Device Combination Products Revenue (US$ Million) by Players (2019-2021) 20
Table 16. Global Drug-Device Combination Products Revenue Market Share by Players (2019-2021) 21
Table 17. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020) 22
Table 18. Founded Date of Key Drug-Device Combination Products Players 23
Table 19. Global Drug-Device Combination Products Top Players Headquarters and Area Served 23
Table 20. Drug-Device Combination Products Product Solution and Service 24
Table 21. Global Drug-Device Combination Products Players Market Concentration Ratio (CR5 and HHI) 25
Table 22. Mergers & Acquisitions, Expansion Plans 26
Table 23. Global Market Drug-Device Combination Products Market Size (US$ Million) Comparison by Region: 2016 VS 2021 VS 2027 28
Table 24. Global Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million) 29
Table 25. Global Drug-Device Combination Products Market Size Share by Region (2016-2021) 30
Table 26. Global Drug-Device Combination Products Forecasted Market Size by Region (2022-2027) & (US$ Million) 30
Table 27. Global Drug-Device Combination Products Forecasted Market Size Share by Region (2022-2027) 30
Table 28. Global Drug-Device Combination Products Market Size (US$ Million) By Application: 2016 VS 2021 VS 2027 34
Table 29. Global Drug-Device Combination Products Market Size by Application (2016-2021) & (US$ Million) 36
Table 30. Global Drug-Device Combination Products Revenue Market Share by Application (2016-2021) 36
Table 31. Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027) & (US$ Million) 36
Table 32. Global Drug-Device Combination Products Revenue Market Share by Application (2022-2027) 37
Table 33. North America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million) 37
Table 34. Europe Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million) 38
Table 35. Asia-Pacific Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million) 39
Table 36. South America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million) 40
Table 37. South America Drug-Device Combination Products Revenue Market Share by Application (2016-2021) 41
Table 38. Middle East and Africa Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million) 41
Table 39. North America Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million) 43
Table 40. North America Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million) 43
Table 41. Europe Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million) 46
Table 42. Europe Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million) 46
Table 43. Europe Drug-Device Combination Products Market Share by Country (2016-2021) 46
Table 44. Europe Drug-Device Combination Products Market Share by Country (2022-2027) 47
Table 45. Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million) 51
Table 46. Asia-Pacific Drug-Device Combination Products Market Size by Region (2022-2027) & (US$ Million) 51
Table 47. Asia-Pacific Drug-Device Combination Products Market Share by Region (2016-2021) 51
Table 48. Asia-Pacific Drug-Device Combination Products Market Share by Region (2022-2027) 52
Table 49. South America Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million) 57
Table 50. South America Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million) 57
Table 51. Middle East & Africa Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million) 59
Table 52. Middle East & Africa Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million) 59
Table 53. GSK Corporation Information 61
Table 54. GSK Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 62
Table 55. GSK Drug-Device Combination Products Product 62
Table 56. GSK Recent Development 64
Table 57. Novo Nordisk Corporation Information 64
Table 58. Novo Nordisk Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 65
Table 59. Novo Nordisk Drug-Device Combination Products Product 66
Table 60. Novo Nordisk Recent Development 66
Table 61. Eli Lilly Corporation Information 66
Table 62. Eli Lilly Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 67
Table 63. Eli Lilly Drug-Device Combination Products Product 67
Table 64. Eli Lilly Recent Development 68
Table 65. AstraZeneca Corporation Information 69
Table 66. AstraZeneca Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 69
Table 67. AstraZeneca Drug-Device Combination Products Product 70
Table 68. AstraZeneca Recent Development 71
Table 69. Sanofi Corporation Information 71
Table 70. Sanofi Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 72
Table 71. Sanofi Drug-Device Combination Products Product 72
Table 72. Sanofi Recent Development 73
Table 73. Boston Scientific Corporation Information 73
Table 74. Boston Scientific Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 74
Table 75. Boston Scientific Drug-Device Combination Products Product 75
Table 76. Boston Scientific Recent Development 76
Table 77. Abbott Corporation Information 76
Table 78. Abbott Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 77
Table 79. Abbott Drug-Device Combination Products Product 77
Table 80. Boehringer Ingelheim Corporation Information 78
Table 81. Boehringer Ingelheim Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 79
Table 82. Boehringer Ingelheim Drug-Device Combination Products Product 79
Table 83. Boehringer Ingelheim Recent Development 80
Table 84. Medtronic Corporation Information 81
Table 85. Medtronic Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 82
Table 86. Medtronic Drug-Device Combination Products Product 82
Table 87. Medtronic Recent Development 83
Table 88. Mylan Corporation Information 83
Table 89. Mylan Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 84
Table 90. Mylan Drug-Device Combination Products Product 85
Table 91. Mylan Recent Development 86
Table 92. 3M Corporation Information 86
Table 93. 3M Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 87
Table 94. 3M Drug-Device Combination Products Product 87
Table 95. Hisamitsu Corporation Information 88
Table 96. Hisamitsu Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 89
Table 97. Hisamitsu Drug-Device Combination Products Product 90
Table 98. Smith & Nephew Corporation Information 90
Table 99. Smith & Nephew Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 91
Table 100. Smith & Nephew Drug-Device Combination Products Product 91
Table 101. Smith & Nephew Recent Development 93
Table 102. Molnlycke Corporation Information 93
Table 103. Molnlycke Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 94
Table 104. Molnlycke Drug-Device Combination Products Product 94
Table 105. Teleflex Corporation Information 95
Table 106. Teleflex Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 96
Table 107. Teleflex Drug-Device Combination Products Product 96
Table 108. Teleflex Recent Development 97
Table 109. BD Corporation Information 97
Table 110. BD Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 98
Table 111. BD Drug-Device Combination Products Product 98
Table 112. Lepu Medical Corporation Information 99
Table 113. Lepu Medical Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 100
Table 114. Lepu Medical Drug-Device Combination Products Product 100
Table 115. MicroPort Corporation Information 102
Table 116. MicroPort Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 103
Table 117. MicroPort Drug-Device Combination Products Product 103
Table 118. Terumo Corporation Information 104
Table 119. Terumo Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 105
Table 120. Terumo Drug-Device Combination Products Product 105
Table 121. B. Braun Corporation Information 106
Table 122. B. Braun Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 107
Table 123. B. Braun Drug-Device Combination Products Product 107
Table 124. Antares Pharma Corporation Information 109
Table 125. Antares Pharma Drug-Device Combination Products Revenue (US$ Million) and Gross Margin (2019-2021) 110
Table 126. Antares Pharma Drug-Device Combination Products Product 110
Table 127. Raw Materials Key Suppliers Lists 112
Table 128. Drug-Device Combination Products Market Trends 114
Table 129. Drug-Device Combination Products Market Drivers 115
Table 130. Drug-Device Combination Products Market Challenges 116
Table 131. Drug-Device Combination Products Market Restraints 116
Table 132. Drug-Device Combination Products Distributors List 118
Table 133. Drug-Device Combination Products Downstream Customers 119
Table 134. Research Programs/Design for This Report 124
Table 135. Key Data Information from Secondary Sources 127
Table 136. Key Data Information from Primary Sources 128
List of Figures
Figure 1. Drug-Device Combination Products Product Picture 2
Figure 2. Global Drug-Device Combination Products Market Size Year-over-Year 2016-2027 & (US$ Million) 3
Figure 3. Global Drug-Device Combination Products Market Size, (US$ Million), 2016 VS 2021 VS 2027 3
Figure 4. Product Picture of Drug-Coated Device 4
Figure 5. Drug-Coated Device Market Size (US$ Million) & YoY Growth (2016-2027) 5
Figure 6. Product Picture of Prefilled Drug Delivery Systems 6
Figure 7. Prefilled Drug Delivery Systems Market Size (US$ Million) & YoY Growth (2016-2027) 7
Figure 8. Product Picture of Nebulizer & Inhaler 8
Figure 9. Nebulizer & Inhaler Market Size (US$ Million) & YoY Growth (2016-2027) 9
Figure 10. Product Picture of Transdermal Delivery System 9
Figure 11. Transdermal Delivery System Market Size (US$ Million) & YoY Growth (2016-2027) 10
Figure 12. Global Drug-Device Combination Products Revenue by Type (2016-2027) & (US$ Million) 11
Figure 13. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021) 13
Figure 14. Global Drug-Device Combination Products Revenue Market Share by Type (2022-2027) 14
Figure 15. North America Drug-Device Combination Products Revenue Market Share by Type in 2020 15
Figure 16. Europe Drug-Device Combination Products Revenue Market Share by Type in 2020 16
Figure 17. Asia-Pacific Drug-Device Combination Products Revenue Market Share by Type in 2020 17
Figure 18. South America Drug-Device Combination Products Revenue Market Share by Type in 2020 18
Figure 19. Middle East and Africa Drug-Device Combination Products Revenue Market Share by Type in 2020 19
Figure 20. Global Top 5 Players Drug-Device Combination Products Market Share in 2020 26
Figure 21. Global Drug-Device Combination Products Market Share by Region: 2021 28
Figure 22. Global Drug-Device Combination Products Market Share by Region: 2027 29
Figure 23. Global Drug-Device Combination Products Forecasted Market Size Share by Region (2022-2027) 31
Figure 24. Product Picture of Hospital & Clinic 32
Figure 25. Global Hospital & Clinic Revenue YoY Growth (2016-2027) & (Million USD) 33
Figure 26. Product Picture of Retail Pharmacies 33
Figure 27. Global Retail Pharmacies Revenue YoY Growth (2016-2027) & (Million USD) 34
Figure 28. Global Drug-Device Combination Products Market Size Share by Application in 2021 35
Figure 29. Global Drug-Device Combination Products Market Size Share by Application in 2027 35
Figure 30. North America Drug-Device Combination Products Revenue Market Share by Application 2016-2021 38
Figure 31. Europe Drug-Device Combination Products Revenue Market Share by Application (2016-2021) 39
Figure 32. Asia-Pacific Drug-Device Combination Products Revenue Market Share by Application (2016-2021) 40
Figure 33. Middle East and Africa Drug-Device Combination Products Revenue Market Share by Application (2016-2021) 42
Figure 34. North America Drug-Device Combination Products Market Share by Country (2016-2027) 44
Figure 35. United States Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 44
Figure 36. Canada Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 45
Figure 37. Mexico Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 45
Figure 38. Germany Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 47
Figure 39. France Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 48
Figure 40. U.K. Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 48
Figure 41. Italy Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 49
Figure 42. Russia Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 49
Figure 43. Rest of Europe Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 50
Figure 44. Asia-Pacific Drug-Device Combination Products Market Share by Region (2016-2027) 52
Figure 45. China Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 53
Figure 46. Japan Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 53
Figure 47. South Korea Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 54
Figure 48. Southeast Asia Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 55
Figure 49. India Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 55
Figure 50. Australia Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 56
Figure 51. Rest of Asia-Pacific Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 56
Figure 52. South America Drug-Device Combination Products Market Share by Country (2016-2027) 57
Figure 53. Brazil Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 58
Figure 54. Rest of South America Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 58
Figure 55. Middle East & Africa Drug-Device Combination Products Market Share by Country (2020) 59
Figure 56. Middle East Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 60
Figure 57. Africa Drug-Device Combination Products Market Size (2016-2027) & (US$ Million) 60
Figure 58. Key Raw Materials Market Concentration Rate 112
Figure 59. Drug-Device Combination Products Industrial Chain Analysis 114
Figure 60. Channels of Distribution 117
Figure 61. Distributors Profiles 118
Figure 62. Bottom-up and Top-down Approaches for This Report 126
Figure 63. Data Triangulation 127

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs